Journal of Clinical Microbiology · 2001 · 49 citations · 44 references
Life SciencesInfectious DiseasesMicrobiologyDiagnostic MicrobiologyMedical MicrobiologyVirologyInfectious Disease DetectionInfectious Disease Molecular TestingPathogen DetectionPolymerase Chain ReactionViral DiagnosticsDiagnostic Assay DevelopmentFluorescence Resonance Energy TransferInterrater AgreementMolecular Detection AssaysParvovirus B19 Infection DiagnosisPcr-based DetectionPolymerase Chain Reaction (Pcr) AssaysQuantitative Pcr Detection
Detection of parvovirus B19 DNA offers diagnostic advantages over serology, particularly in persistent infections of immunocompromised patients. A rapid, novel method of B19 DNA detection and quantification is introduced. This method, a quantitative PCR assay, is based on real-time glass capillary thermocycling (LightCycler [LC]) and fluorescence resonance energy transfer (FRET). The PCR assay allowed quantification over a dynamic range of over 7 logs and could quantify as little as 250 B19 genome equivalents (geq) per ml as calculated for plasmid DNA (i.e., theoretically >or=5 geq per assay). Interrater agreement analysis demonstrated equivalence of LC-FRET PCR and conventional nested PCR in the diagnosis of an active B19 infection (kappa coefficient = 0.83). The benefit of the new method was demonstrated in an immunocompromised child with a relapsing infection, who required an attenuation of the immunosuppressive therapy in addition to repeated doses of immunoglobulin to eliminate the virus.
44
Erythrocyte P Antigen: Cellular Receptor for B19 Parvovirus
Kevin Brown, Stacie M. Anderson, Neal S. Young · Science · 1993 · 859 citations
Chronic Bone Marrow Failure Due to Persistent B19 Parvovirus Infection
Gary J. Kurtzman, Keiya Ozawa, Bernard Cohen et al. · New England Journal of Medicine · 1987 · 459 citations